Stonehage Fleming Financial Services Holdings LTD Moderna, Inc. Transaction History

Stonehage Fleming Financial Services Holdings LTD

$3.78 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $147,587 - $242,725	1,250 New	1,250 $147,000
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $63,230 - $117,525	-500 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $45,164 - $73,702	-200 Reduced 28.57%	500 $126,000
Q2 2021 Aug 06, 2021	SELL	$129.91 - $234.98 $194,865 - $352,470	-1,500 Reduced 68.18%	700 $164,000
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $43,672 - $74,392	400 Added 22.22%	2,200 $288,000
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $118,331 - $305,748	1,800 New	1,800 $188,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Account